Corpus Intelligence IC Memo — ST. ELIZABETH HOSP. OF WABASHA INC. 2026-04-26 16:36 UTC
IC Memo — ST. ELIZABETH HOSP. OF WABASHA INC.
Investment Committee Memorandum | MN | 14 beds | Grade D | EBITDA uplift $2.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST. ELIZABETH HOSP. OF WABASHA INC.

CCN 241335 | WABASHA, MN | 14 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ST. ELIZABETH HOSP. OF WABASHA INC. is a 14-bed community hospital in WABASHA, MN with $38.1M in net patient revenue and a -7.3% operating margin. The hospital serves a payer mix of 51.0% Medicare, 0.0% Medicaid, and 49.0% commercial.

Thesis: Turnaround. Our ML models identify $2.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.3% to 0.1% (+736bps).

Net Revenue HCRIS$38.1M
Current EBITDA COMPUTED$-2.8M
Operating Margin COMPUTED-7.3%
Occupancy HCRIS37.6%
Revenue / Bed COMPUTED$2.7M
Net-to-Gross HCRIS75.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

141
MN Hospitals
-3.6%
State Median Margin
85
Comparable Hospitals

MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -7.3% places it below the state median. Among 85 size-comparable peers (7-28 beds), the median margin is -2.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (7-28), prioritizing same-state peers. 85 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST. ELIZABETH HOSP. OF WABASHA (Target)MN14$38.1M-7.3%
CUYUNA REGIONAL MEDICAL CENTERMN25$180.8M-4.0%
MAYO CLINIC HEALTH SYSTEM - REMN27$149.3M1.8%
NEW ULM MEDICAL CENTERMN24$128.6M4.2%
LAKEWOOD HEALTH SYSTEMMN25$124.7M0.2%
AVERA MARSHALL REGIONAL MEDICAMN25$115.2M-17.0%
WELIA HEALTHMN25$106.7M1.1%
CCH-MONTICELLOMN25$97.7M9.2%
RIVERWOOD HEALTHCARE CENTERMN25$85.5M-2.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$800K+210bp18mo
Cost to Collect4.5%2.5%$762K+200bp12mo
Denial Rate Reduction12.0%6.5%$754K+198bp12mo
A/R Days Reduction5200.0%3800.0%$464K+122bp9mo
Clean Claim Rate88.0%96.0%$24K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$800K
Cost to Collect
$762K
Denial Rate Reduction
$754K
A/R Days Reduction
$464K
Clean Claim Rate
$24K
Total EBITDA Uplift$2.8M
Current EBITDA$-2.8M
+ RCM Uplift+$2.8M
Pro Forma EBITDA$40K
Current Margin-7.3%
Pro Forma Margin0.1%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.3M$9.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.3M$9.4M0.00x-100.0%
Bull Case9.0x11.0x$-3.8M$17.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.8M$17.7M0.00x-100.0%
Bear Case11.0x10.0x$-4.7M$-2.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.7M$-4.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 85 hospitals with 7-28 beds
  • Same-state prioritization (n=89)
  • Comp margins: P25=-13.2% / P50=-2.6% / P75=3.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.